Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

J. Cortes, D. W. Kim, E. Raffoux, G. Martinelli, E. Ritchie, L. Roy, S. Coutre, S. Corm, N. Hamerschlak, J. L. Tang, A. Hochhaus, H. J. Khoury, T. H. Brümmendorf, M. Michallet, G. Rege-Cambrin, C. Gambacorti-Passerini, J. P. Radich, T. Ernst, C. Zhu, J. M.A. Van TornoutM. Talpaz

Research output: Contribution to journalArticlepeer-review

163 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase'. Together they form a unique fingerprint.

Medicine & Life Sciences